Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-07 · accession 0001219036-21-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-08 | 2021-07-07 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $26.49 | +32.3K | 234.4K | +16% | +$855.8K |
| DM | 2021-07-08 | 2021-07-07 | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $32.27 | -32.3K | 232.6K | -12% | -$1.04M |
| DM | 2021-07-08 | 2021-07-07 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $0.00 | -32.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-07 | M | A | 30,424 | $26.49 | 262,974 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-07 | S | D | 30,424 | $32.29 | 232,550 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-07 | M | A | 1,884 | $26.49 | 234,434 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-07 | S | D | 1,884 | $31.99 | 232,550 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-07 | M | D | 30,424 | $0.00 | 141,828 | D | $26.49 · — to 2021-09-17 | 30,424 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |
| 6 | Derivative | Incentive Stock Option (right to buy) | 2021-07-07 | M | D | 1,884 | $0.00 | 0 | D | $26.49 · — to 2021-09-17 | 1,884 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |